Antibody Characterization via Homogeneous Fluorescence Assays
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for characterizing monoclonal antibodies, particularly for internalization, complement-dependent cytotoxicity (CDC), and antibody-dependent cellular cytotoxicity (ADCC), are limited by lack of high-throughput capabilities, requiring laborious and inaccurate assays that are not suitable for early drug discovery.
Innovation Solution
Development of high-throughput methods using fluorescently labeled Fab fragments for internalization assays, and dual-stain techniques with anthraquinone and cyanine dyes for CDC and ADCC assays, allowing for homogenous, rapid, and sensitive detection of antibody characteristics without the need for physical separation or washing steps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional internalization assays are used, then detection of antibody internalization is possible, but the methods are laborious and not suitable for high throughput
Solution Approach 1:
The patent replaces complex mechanical washing and separation steps with a homogeneous fluorescence-based detection system. Antibodies are directly labeled with fluorophores, eliminating the need for physical separation of internalized from surface-bound antibodies, thereby enabling high-throughput screening without laborious manual operations
Solution Approach 2:
The patent changes the detection parameter from requiring physical separation to measuring fluorescence intensity directly in homogeneous samples. By using fluorophore-labeled antibodies and measuring fluorescence without washing steps, the assay transforms from a multi-step mechanical process to a simple optical measurement suitable for automated high-throughput screening
2Measurement precision
If conventional CDC assays are used, then complement-dependent cytotoxicity can be measured, but the methods require high antibody concentrations and are not accurate
Solution Approach 1:
The patent replaces conventional CDC assay methods with a fluorescence-based detection system that directly measures complement-mediated cell lysis. This substitution enables accurate measurement at lower antibody concentrations by using fluorophore-labeled target cells and detecting fluorescence changes that indicate cell membrane integrity loss, eliminating the need for high antibody concentrations required by traditional methods
3Productivity
If conventional ADCC assays are used, then antibody-dependent cellular cytotoxicity can be measured, but the methods are not suitable for high throughput
Solution Approach 1:
The patent replaces complex mechanical ADCC assays with a homogeneous fluorescence-based system. By labeling target cells with fluorophores and measuring fluorescence intensity changes that indicate effector cell-mediated lysis, the assay eliminates complex device requirements and enables automated high-throughput screening of antibody candidates
Solution Approach 2:
The patent changes the measurement parameter from complex cellular interactions requiring specialized equipment to simple fluorescence intensity measurements. This parameter change allows ADCC activity to be assessed in a homogeneous format suitable for automated plate readers and high-throughput screening platforms
4Measurement precision
If washing steps are used for reporter dissociation, then specific detection of internalized antibodies is possible, but the process is time-consuming and reduces throughput
Solution Approach 1:
The patent replaces mechanical washing steps required for reporter dissociation with direct fluorescence labeling of antibodies. By covalently attaching fluorophores to antibodies before incubation with target cells, the method eliminates the need for post-incubation washing steps while maintaining the ability to specifically detect internalized antibodies through fluorescence microscopy or flow cytometry
Solution Approach 2:
The patent performs the labeling action in advance by pre-conjugating antibodies with fluorophores before the internalization assay. This preliminary action eliminates the need for time-consuming washing and separation steps during the assay itself, as the fluorescent label remains attached to the antibody throughout the process, enabling rapid detection without loss of time
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the selection of antibodies based on internalization, CDC, and ADCC capabilities in a high-throughput format, providing accurate and sensitive analysis of low antibody concentrations directly from crude supernatants, suitable for early drug discovery and therapeutic applications.
Implementation Method 1
providing a Fab fragment capable of binding said antibodies, wherein said Fab fragment i) does not mediate internalization, and ii) comprises a fluorescent label, d) incubating said samples, cells and Fab fragment in a test vial under conditions that allow formation and internalization of a complex comprising said antigen, antibody and Fab fragment, e) detecting fluorescence of at least a cell-containing subvolume of said test vial
Implementation Method 2
providing complement, d) incubating said sample, target cells and complement under conditions that allow complement activation and target cell lysis, e) adding a first and a second dye, wherein the first dye is an anthraquinone or derivative thereof, and the second dye is a cyanine dye composed of a quinoline and a benzothiazole moiety, and f) performing count measurements of individual cells, wherein the reading discriminates between cells that are stained with both the first and the second dye
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention relates to methods for the characterization of monoclonal antibodies, in particular high throughput methods for the characterization of antibodies with respect to internalization and complement activation.